Fibromyalgia Trial, Recruiting NCT07304167 Sponsor: Halic University Condition: Fibromyalgia
Back to Fibromyalgia

Fibromyalgia Trial, Recruiting

NCT07304167
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman between 30 and 70 years old
  • You have been officially diagnosed with fibromyalgia
  • You are willing to take part in the study and sign a consent form
  • Your fibromyalgia diagnosis meets specific scoring thresholds based on a recognised 2016 medical guideline for widespread pain and symptom severity (confirm with trial site)

Who may not be able to join:

  • You are currently pregnant or breastfeeding
  • You have a serious condition affecting your bones, joints, or muscles that means exercise is not safe for you (such as arthritis, osteoarthritis, or gout-related disorders)
  • You have epilepsy
  • You have a history of severe headaches
  • You have a neurological condition (a condition affecting the brain or nervous system)
  • You have a condition affecting the nerves in your hands, feet, or limbs (confirm with trial site)
  • You have a serious heart or blood pressure condition, such as uncontrolled high blood pressure, heart failure, or you have a pacemaker
  • You have a bone or joint problem in your arms or legs that stops you from doing physical activity
  • You have another rheumatic disease in addition to fibromyalgia
  • You have a collapsed lung (confirm with trial site)
  • You have or have had cancer
  • You have had surgery in the last four months
  • You have a serious mental health condition, such as uncontrolled depression or anxiety, dementia, or a personality disorder
  • You have alcohol dependence or regularly use recreational drugs or narcotics
  • You have taken part in any regular exercise programme in the two months before the study starts
  • Your body mass index (BMI — a measure of body weight relative to height) is above 29.9

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gülhan Fetin, PT, Halic University

Phone: +905077218827

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Halic University
Registry
ClinicalTrials.gov
Start date
15 December 2025
Est. completion
28 February 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Revised Fibromyalgia Impact Questionnaire; Fibromyalgia Severity Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov